Elizabeth Fleurisma tears up as she runs her arms over the scars that map her scalp.
The Lengthy Island mother used to be shocked to find on the age of 30 that she had a mind tumor the dimensions of a lime.
She survived a 16-hour surgical procedure and weeks of radiation — but a work of the tumor stays lodged in her cranium, disrupting her day by day existence.
“Once I got here out of surgical procedure, once I got here house, it’s nearly like I didn’t even know my atmosphere,” Fleurisma, who turns 33 this week, advised The Submit.
“Now and again once I’m looking to talk, I’ll omit a phrase,” she added. “It’s now not simple therapeutic from this stuff or getting again to the place you left off.”
Fleurisma, who lives in Centereach, believes her meningioma got here from using Depo-Provera delivery keep an eye on for 8 years.
She’s one in all 75 New Yorkers suing Pfizer, the producer of Depo-Provera, for allegedly failing to adequately warn customers of the larger possibility of probably devastating mind tumors.
“I’ve filed instances on behalf of about 150 ladies and feature many different purchasers that we’re nonetheless comparing, and Elizabeth’s tumor is the most important of the entire ones I’ve observed,” Fleurisma’s legal professional, Ellen Relkin, advised The Submit.
Over 1,700 proceedings were one by one filed in federal courtroom. Plaintiffs declare that Pfizer knew or will have to have recognized in regards to the upper meningioma possibility however deliberately hid this data to give protection to income.
Pfizer advised The Submit that it “believes those claims are with out benefit and can vigorously protect towards those allegations.”
The commentary endured: “The Corporate stands at the back of the protection and efficacy of Depo-Provera, which has been utilized by hundreds of thousands of girls international and stays the most important remedy choice for girls searching for to regulate their reproductive well being.”
What’s Depo-Provera?
Reproductive well being used to be best of thoughts for Fleurisma after she gave delivery to her son in 2011 on the age of 18.
She experimented with delivery keep an eye on capsules, however discovered that she struggled to take them constantly.
Her gynecologist instructed Depo-Provera, a well-liked contraceptive that has been used someday by way of just about 25% of sexually energetic ladies.
The injection is given within the higher arm or buttock each and every 3 months.
It incorporates progestin, an artificial hormone that forestalls being pregnant by way of pausing ovulation, blockading sperm from attaining any eggs and making the uterine lining improper for implantation.
Analysis suggests that extended use of positive progestins — together with medroxyprogesterone acetate, like in Depo-Provera — considerably will increase the chance of creating intracranial meningiomas.
“The connection between intercourse hormones and meningioma tumors has been recognized because the Twenties, and the presence of progesterone receptors in meningioma tissue has been reported because the Seventies,” Fleurisma’s go well with reads.
“A number of medical research have established that progesterone, its artificial analogue progestin, and Depo-Provera particularly, reason and/or considerably give a contribution to the improvement and expansion of intracranial meningioma tumors.”
Those slow-growing tumors rise up from the meninges, the membranes that offer protection to the mind and spinal wire. They’re normally benign, that means they don’t most often unfold like most cancers, however they are able to press on within reach mind tissue, nerves or vessels.
Fleurisma doesn’t recall her gynecologist speaking along with her about imaginable uncomfortable side effects of Depo-Provera, best that there used to be an excessively narrow probability she may get pregnant.
Attainable uncomfortable side effects indexed at the label come with bone mineral density loss, a quite larger possibility of breast most cancers, blood clots, stroke, ectopic being pregnant, serious hypersensitive reactions and lack of imaginative and prescient, amongst others. Meningiomas aren’t discussed.
Pfizer claims it requested america Meals and Drug Management so as to add a caution after reviewing new analysis in 2023 suggesting a hyperlink between Depo-Provera use and meningiomas, in step with Reuters.
The FDA reportedly rejected the request, pronouncing that “the findings of the to be had observational research on my own don’t enhance the addition of a caution.” Pfizer resubmitted the FDA software in June 2025.
Within Fleurisma’s emotional fight
Fleurisma mentioned she began taking Depo-Provera in 2014 on the age of 21. She had no factor till early 2023.
“I used to be having serious complications, fatigue,” Fleurisma recalled. “It used to be excruciating ache that I saved feeling, and I wasn’t ready to endure it anymore.”
She rushed to the medical institution one night time after feeling her temperature emerging. Docs printed the unthinkable — a mind tumor.
“It used to be very surprising information, as a result of I’ve by no means been via a disaster like this sooner than,” Fleurisma mentioned.
The months that ensued are a blur. She had a craniotomy in July 2023 at Stony Brook College Clinic, however now not the entire tumor might be got rid of.
That intended she needed to go through radiation 5 instances every week for roughly a month, a complete of 27 periods, in step with her lawsuit.
Those appointments, every lasting not up to two hours, had her dressed in a radiation masks that appeared find it irresistible got here out of “Celebrity Wars.”
The masks held her head and neck in position, taking into consideration exact supply of the radiation.
“You kind of simply lay there,” Fleurisma mentioned of the remedy.
“[The staff asked], ‘What do you want to hear to lend a hand stay calm?’ ” she added. “And I’m simply considering of the following holiday I need to take, my favourite meals, to stay your thoughts off of what’s really occurring.”
At the highway to restoration
Restoration has challenged Fleurisma at each and every flip, from the massive hurdles to the tiny frustrations.
She despatched her son, now 14, to briefly are living together with his father as a result of she may now not handle him.
And she or he watched in horror because the scars took form and her hair fell out.
The battle isn’t over. Fleurisma meets along with her radiologist every year to ensure the remainder tumor piece hasn’t grown.
She mentioned in her go well with that she nonetheless studies imaginative and prescient troubles, complications, nausea and dizziness.
Earlier than this ordeal, Fleurisma labored as a residential supervisor supporting adults with highbrow and developmental disabilities.
“Once I came upon in regards to the analysis, the whole thing stopped from there as a result of I couldn’t endure those complications at paintings,” she mentioned.
“I used to be within the strategy of recertifying [as a certified nursing assistant] and in addition changing into a psychological well being hygienist, so all of this stuff had been placed on cling. Two years later, now I’m again the place I began, so it’s now not simple.”
She’s now learning to transform a scientific assistant within the hopes of becoming a member of the pediatrics box.
Fleurisma stopped taking Depo-Provera in 2023 at the recommendation of her neurosurgeon.
She sued Pfizer in March 2025 to “let ladies know that they have got a voice.”
“Some ladies … don’t ask questions, and that’s what I didn’t do,” she added. “You may have a voice, you talk in your well being, and also you care for your well being.”
